DOI QR코드

DOI QR Code

Mortality of Major Cancers in Guangxi, China: Sex, Age and Geographical Differences from 1971 and 2005

  • Deng, Wei (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Long, Long (Department of Computer Science and Information Technology, Guangxi Teachers Education University) ;
  • Li, Ji-Lin (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Zheng, Dan (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Yu, Jia-Hua (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Zhang, Chun-Yan (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Li, Ke-Zhi (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Liu, Hai-Zhou (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University) ;
  • Huang, Tian-Ren (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
  • Published : 2014.02.28

Abstract

The incidence and mortality rates of liver and nasopharyngeal cancer in Guangxi province of China have always been among the highest in the world, and cancer is one of the major diseases that pose a threat to the health of residents in Guangxi. However, no systematic study has been performed to evaluate the time trends in the structure of cancer-related deaths and cancer mortality. In this study, we reveal sex, age and geography differences of cancers mortality between three death surveys (1971 to 1973, 1990 to 1992, and 2004 to 2005). The results show that the standardized mortality rate of cancer in Guangxi residents has risen from 43.3/100,000 to 84.2/100,000, the share of cancer deaths in all-cause deaths has increased from 13.3% to 20.7%, and cancer has become the second most common cause of death. The five major cancers, liver cancer, lung cancer, gastric cancer, nasopharyngeal cancer and colorectal cancer, account for 60% of all the cancer deaths. Cancers with growing mortality rates over the past 30 years include lung cancer, colorectal cancer, liver cancer and female breast cancer, of which lung cancer is associated with the sharpest rise in mortality, with a more than 600% rise in both men and women. Cancer death in Guangxi residents occurs mainly in the elderly population above 45 years of age, especially in people over the age of 65. The areas with the highest mortality rates for liver cancer and nasopharyngeal cancer, which feature regional high incidences, include Chongzuo and Wuzhou. Therefore, for major cancers such as liver cancer, lung cancer, gastric cancer, nasopharyngeal cancer and female breast cancer in Guangxi, we can select high-risk age groups as the target population for cancer prevention and control efforts in high-prevalence areas in a bid to achieve the ultimate goal of lowering cancer mortality in Guangxi.

Keywords

Cancer;mortality;Guangxi;China;1971-2005

References

  1. Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pacific J Cancer Prev, 14, 6227-31. https://doi.org/10.7314/APJCP.2013.14.11.6227
  2. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al (2008). Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med, 149, 659-69. https://doi.org/10.7326/0003-4819-149-9-200811040-00244
  3. Zhao P, Kong LZ (2010). Cancer death report - the third retrospective sampling survey of death causes, China. First edition, Beijing: People's medical publishing house.
  4. Zhu YR (2012). Research progress in prevention of major risk factors of liver cancer in Qidong. China Cancer, 21,759-62.
  5. Sankaranarayanan R, Nene BM, Shastri SS, et al (2009). HPV screening for cervical cancer in rural India. N Engl J Med, 360, 1385-94. https://doi.org/10.1056/NEJMoa0808516
  6. Moore MA. (2013). Overview of cancer registration research in the Asian Pacific from 2008-2013. Asian Pac J Cancer Prev, 14, 4461-84. https://doi.org/10.7314/APJCP.2013.14.8.4461
  7. Okamoto E. (2013). Cohort analysis of incidence/mortality of liver cancer in japan through logistic curve fitting. Asian Pac J Cancer Prev, 14, 5891-93. https://doi.org/10.7314/APJCP.2013.14.10.5891
  8. Zheng RS, Zhang SW, Wu LY, et al (2012). Report of incidence and mortality from china cancer registries in 2008. China Cancer, 1, 1-12.
  9. Sherris J, Wittet S, Kleine A, et al (2009). Evidence-based, alternative cervical cancer screening approaches in lowresource settings. Int Perspect Sex Reprod Health, 35, 147-52. https://doi.org/10.1363/3514709
  10. Spitz M, Wu X, Wilkinson A, et al (2006). Cancer of the lung. Cancer Epidemiol Prev, 3, 638-58.
  11. Thun MJ, Hannan LM, Adams-Campbell LL, et al (2008). Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5, e185. https://doi.org/10.1371/journal.pmed.0050185
  12. Turner P, Sylla A, Gong Y, et al (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet, 365, 1950-56. https://doi.org/10.1016/S0140-6736(05)66661-5
  13. World Health Organization (2009). WHO Vaccine-Preventable Diseases: Monitoring System: 2009 Global Summary.
  14. World Health Organization (2010). Framework Convention On Tobacco Control. 2003. Geneva, Switzerland.
  15. Yao H, Shi L. (2003). Meta-analysis of the risk factors on lung cancer in Chinese people. Chinese J Epidemiology, 24, 45-9.
  16. He J, Chen WQ (2010). Annual Report of Cancer Registration in China. Beijing: Military Medical Science Press 2012, 10.
  17. Ferrari P, Jenab M, Norat T, et al (2007). Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 121, 2065-72. https://doi.org/10.1002/ijc.22966
  18. Garcia-Alvarez A, Serra-Majem L, Ribas-Barba L, et al (2007). Obesity and overweight trends in Catalonia, Spain (1992- 2003): gender and socio-economic determinants. Public Health Nutr, 10, 1368-78.
  19. Gwack J, Park SK, Lee E-H, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12 2205-8.
  20. Hulka BS, Moorman PG. (2008). Reprint of Breast cancer: hormones and other risk factors. Maturitas, 61, 203-13. https://doi.org/10.1016/j.maturitas.2008.11.016
  21. Ito K, Tsunematsu M, Satoh K, et al (2013). Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry. Asian Pac J Cancer Prev, 14, 4897-902. https://doi.org/10.7314/APJCP.2013.14.8.4897
  22. Kushi LH, Byers T, Doyle C, et al (2006). American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 56, 254-81. https://doi.org/10.3322/canjclin.56.5.254
  23. Mandel JS, Bond JH, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med, 328, 1365-71. https://doi.org/10.1056/NEJM199305133281901
  24. Ming L, Thorgeirsson SS, Gail MH, et al (2002). Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36, 1214-20. https://doi.org/10.1053/jhep.2002.36366
  25. Colditz GA, Sellers TA, Trapido E. (2005). Epidemiologyidentifying the causes and preventability of cancer? Nat Rev, 6, 75-83. https://doi.org/10.1038/nrg1505
  26. Centers for Disease Control and Prevention (2007). Best Practices for Comprehensive Tobacco Control Programs. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  27. Chang MH. (2014). Prevention of Hepatitis B Virus Infection and Liver Cancer. in: Viruses and Human Cancer, Springer, pp. 75-95.
  28. Cho E, Kang MH, Choi S, et al (2013). Cost-effectiveness of Korea's national cervical cancer screening program. Asian Pac J Cancer Prev, 14, 4329-34. https://doi.org/10.7314/APJCP.2013.14.7.4329
  29. Cucchetti A, Cescon M, Erroi V, Pinna AD. (2013). Costeffectiveness of liver cancer screening. Best Pract Res Clin Gastroenterol, 27, 961-72. https://doi.org/10.1016/j.bpg.2013.08.021
  30. de Groot P, Munden RF. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am, 50, 863-76. https://doi.org/10.1016/j.rcl.2012.06.006
  31. Dong ZW, Qiao YL, Li LD, et al.. (2009). A report of cancer high incidence scene in China. China Cancer, 1, 4-9.
  32. Dong ZW(2002). Prevention and treatment for cancer, a longlasting approach. China Cancer, 11, 2-3.
  33. Fan1 J-H, Wang J-B, Jiang Y, et al (2013). Attributable causes of liver cancer mortality and incidence in China. Asian Pac J Cancer Prev, 14, 7251-56. https://doi.org/10.7314/APJCP.2013.14.12.7251
  34. Ferlay J, Bray F, Pisani P, Parkin D. (2007). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0, IARCPress, Lyon, 2004. Valero-Malaria in Colombia, 195.
  35. Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer, 113, 2221-43. https://doi.org/10.1002/cncr.23844
  36. Atkin WS, Edwards R, Kralj-Hans I, et al (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet, 375, 1624-33. https://doi.org/10.1016/S0140-6736(10)60551-X
  37. Center MM, Jemal A, Ward E. (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94. https://doi.org/10.1158/1055-9965.EPI-09-0090

Cited by

  1. Targeted Efficacy of Dihydroartemisinin for Translationally Controlled Protein Expression in a Lung Cancer Model vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2511
  2. Glycididazole Sodium Combined with Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2641
  3. Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2685
  4. Anti-Proliferation Effects and Molecular Mechanisms of Action of Tetramethypyrazine on Human SGC-7901 Gastric Carcinoma Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3581
  5. Anti-VEGF Therapy with Bevacizumab - Limited Cardiovascular Toxicity vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10769
  6. Risk Factors and Epidemiology of Gastric Cancer in Pakistan vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4821
  7. Hepatitis B Virus Infection Is Associated with Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5285
  8. Anisotropic Patterns of Liver Cancer Prevalence in Guangxi in Southwest China: Is Local Climate a Contributing Factor? vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3579
  9. Colorectal Cancer: Epidemiological Study, Clinical, Histological and Immunohistochemistry Examination in Patient of West Algeria vol.08, pp.01, 2017, https://doi.org/10.4236/jct.2017.81003
  10. Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China vol.185, pp.12, 2017, https://doi.org/10.1093/aje/kwx018